VEGFA and neoplasm: These include expression of other angiogenic factors produced constitutively (intrinsic resistance) or during anti-VEGF-A treatment (acquired resistance) and/or development of adaptive mechanisms by the tumor cells themselves, including resistance to hypoxia, increased cell motility and survival, and escape from host immune cells [11].